Vicki Moore, PhD

The addition of plerixafor to treatment following transplantation may not enhance lymphocyte recovery in patients with multiple myeloma.

Among patients treated with an acute lymphoblastic leukemia induction regimen, 72% achieved end-of-induction complete remission.

Researchers explored a possible link between TNF-α and peripheral neuropathy in patients with MM treated with bortezomib.

A cross-sectional survey examined Medical Expenditure Panel Survey data on prescriptions for gabapentinoid medications given for pain management in patients with cancer.

A retrospective cohort analysis found that patients with DLBCL who experienced infusion reactions during treatment with rituximab had prolonged overall survival. In addition, progression-free survival was affected in subsets of patients with DLBCL.

Optimal thromboprophylaxis for VTE was found to be essential in patients with NDMM, especially those at high risk.

Using EQ-5D and PedsQL, researchers determined the long-term effect of tisagenlecleucel treatment on quality of life for pediatric and young patients with R/R B-cell ALL.

Patients received 50 mg dasatinib daily and demonstrated 2-year rates of overall and event-free survival of 100%.

A retrospective analysis of more than 7000 patients found a potential association between colorectal cancer, hepatic metastasis, and chronic HBV status.

The guideline includes strategies to identify patients with nonmetastatic cancer who may be at a higher risk for osteoporotic fractures